Line 1: | Line 1: | ||
− | {{Vanderbilt | + | {{Team:Vanderbilt/css/assets.css}} |
− | + | {{Team:Vanderbilt/css/style.css}} | |
− | + | {{Team:Vanderbilt/js/jquery.js}} | |
− | + | {{Team:Vanderbilt/js/assets.js}} | |
− | + | {{Team:Vanderbilt/js/scripts.js}} | |
− | + | {{Team:Vanderbilt/header}} | |
− | + | <html> | |
− | + | <style> | |
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | < | + | |
− | < | + | |
− | + | ||
− | + | ||
+ | #sideMenu, #top_title {display:none;} | ||
+ | body {background-color:white; } | ||
+ | #content { padding:0px; width:100%; margin-top: -125px; margin-left:0px;} | ||
+ | #bodyContent h1, #bodyContent h2, #bodyContent h3, #bodyContent h4, #bodyContent h5 { margin-bottom: 0px; } | ||
+ | </style> | ||
+ | |||
+ | |||
+ | <section class="experience bg-midnight-blue"> | ||
+ | <div class="container"> | ||
+ | <div class="row"> | ||
+ | <div class="col-sm-10"> | ||
+ | <h3>Part Improvement</h3> | ||
+ | <p> RFP-UV (K1673101) had improved characterization in terms of UV irradiation. It was tested through qPCR and immunoblotting, which showed significant decreases in mutation levels in comparison to E1010. Please see the registry page for this part for full characterization and creation. </p> | ||
</html> | </html> |
Revision as of 03:56, 20 October 2016
Part Improvement
RFP-UV (K1673101) had improved characterization in terms of UV irradiation. It was tested through qPCR and immunoblotting, which showed significant decreases in mutation levels in comparison to E1010. Please see the registry page for this part for full characterization and creation.